HEPATIC STEATOSIS
Clinical trials for HEPATIC STEATOSIS explained in plain language.
Never miss a new study
Get alerted when new HEPATIC STEATOSIS trials appear
Sign up with your email to follow new studies for HEPATIC STEATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in shrinking fatty liver
Disease control Recruiting nowThis study tests whether a daily injection of tesamorelin can safely reduce liver fat in adults with metabolic-associated fatty liver disease (MASLD). About 120 participants will receive either the drug or a placebo for 52 weeks, along with lifestyle advice. The main goal is to m…
Matched conditions: HEPATIC STEATOSIS
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New shot aims to tackle fatty liver – early human trial begins
Disease control Recruiting nowThis early-stage study is testing a new medicine called NNC0581-0001 for people with fatty liver and suspected liver inflammation. About 48 adults will receive either the drug or a placebo as a monthly injection for three months. The main goal is to check safety and how the drug …
Matched conditions: HEPATIC STEATOSIS
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
Could a simple ultrasound replace MRI for fatty liver diagnosis?
Diagnosis Recruiting nowThis study is testing a new ultrasound technique called DeepUSFF to see how well it measures liver fat compared to the current gold standard, MRI. About 62 adults with suspected fatty liver disease will get both scans. If successful, this could offer a faster, cheaper, and more a…
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Diagnosis
Last updated May 16, 2026 23:36 UTC
-
Can new scans replace MRI for fatty liver diagnosis?
Diagnosis Recruiting nowThis study aims to see if newer CT and ultrasound techniques can accurately detect fat and scarring in the liver, compared to the current gold standard, MRI. About 45 adults with liver disease will receive a special CT scan, an MRI, and an ultrasound. If successful, these methods…
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: Duke University • Aim: Diagnosis
Last updated May 14, 2026 12:03 UTC
-
New study aims to predict liver disease in HIV patients
Knowledge-focused Recruiting nowThis study looks at 320 people with HIV to create tools that predict who might develop fatty liver disease or liver scarring. The goal is to catch these problems early so doctors can help sooner. Participants will have regular check-ups and liver scans over time.
Matched conditions: HEPATIC STEATOSIS
Sponsor: Shanghai Public Health Clinical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Can a workout change how your liver makes sugar? new study investigates.
Knowledge-focused Recruiting nowThis study looks at how exercise changes the amount of sugar the liver makes in people with type 2 diabetes and fatty liver. Researchers will compare glucose production during rest and exercise in 12 adults aged 25-55. The goal is to understand how exercise might help control blo…
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: AdventHealth Translational Research Institute • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC